← Back to list
FundsmithFund report30 Jun 2013Source: fundsmith.co.uk

Fundsmith Equity Fund Interim Report 2013

Fundsmith is the fund firm Terry Smith ("Britain's Warren Buffett") founded in 2010, with a discipline of radical simplicity — Buy Good Companies, Don't Overpay, Do Nothing: a concentrated book of 20-30 high-ROCE global consumer, healthcare and tech franchises with near-zero turnover. His annual shareholder letters are famous for wit and common sense; peak AUM topped £25bn.

Terry Smith · 2010 · 英国伦敦Quality growth / Concentrated

In plain words

This report covers how the Fundsmith fund performed in the first half of 2013. It returned 21.5%, beating the market by a lot. The fund only buys high-quality companies with strong competitive advantages (like a 'moat'), such as Domino's Pizza, Microsoft, and Procter & Gamble, and trades very rarely (turnover rate of 0.19%, meaning it barely buys or sells). This keeps costs low. For ordinary investors, it shows that picking good companies and holding them long-term can work well. But the manager warns that part of the gain came from stocks getting more expensive, not from better business results, so be cautious. It's worth reading because it demonstrates a simple, disciplined investing approach.

AI SummaryAI-generated · may contain errors · verify against the original

The fund's first-half return was +21.5%, significantly outperforming the MSCI WORLD's +16.4%. During the period, it added Swedish Match and Procter & Gamble, and fully exited Schindler, Serco, and Sigma-Aldrich. The manager emphasized the low turnover rate of 0.19% to control costs, and flagged the

~4 min full read · 5 sections
Deep Analysis

Period Performance

Indicator Fund (T Class Acc) MSCI WORLD £ MSCI EAFE £ FTSE 100
Period Return (01.01.13 - 30.06.13) +21.5% +16.4% +11.8% +7.9%
Return Since Inception (01.11.10 to 30.06.13) 57.3% - - -

Top 10 Holdings

Rank Company Weight as of 30.06.13 Weight as of 31.12.12 Change
1 Domino's Pizza 5.77% 5.18% +0.59%
2 Stryker 5.75% 5.28% +0.47%
3 Dr Pepper Snapple 5.72% 5.60% +0.12%
4 Microsoft 5.35% 4.79% +0.56%
5 Reckitt Benckiser 5.17% 5.60% -0.43%
6 Imperial Tobacco 4.84% 5.24% -0.40%
7 Becton Dickinson and Company 4.76% 4.82% -0.06%
8 Swedish Match 4.50% - New
9 Procter & Gamble 4.45% - New
10 Automatic Data Processing 4.29% 4.91% -0.62%

Major Transactions During the Period

  • New Positions: Swedish Match, Procter & Gamble, a medical device company, and a transaction processing company (the latter two names are undisclosed as the holdings had not yet reached a material threshold).
  • Liquidated Positions: Schindler, Serco, Sigma-Aldrich.
  • Significant Increases: Dr Pepper Snapple (bought £31,789,028), Imperial Tobacco (bought £29,358,622), Stryker (bought £28,752,563).

Fees and Size

Item Value
Total Fund Size (AUM) Approx. £1,484,974,000 (all share classes combined)
Ongoing Charges Figure (OCF) - T Class Acc 1.10%
Ongoing Charges Figure (OCF) - I Class Net Acc 1.00%
Ongoing Charges Figure (OCF) - R Class Acc 1.60%
Total Cost of Investment (TCI) - T Class Acc 1.22% (includes OCF and transaction costs)
Portfolio Turnover Rate 0.19%
Dividend (T Class Acc) 1.3036 pence per share (includes declared but unpaid dividends)

Key Points from Manager Commentary

  • Performance Attribution: The fund's high equity exposure (always fully invested) and the market's preference for "defensive" quality companies together drove the strong outperformance relative to the benchmark in the first half.
  • Valuation Risk Warning: The manager noted that part of the return came from valuation expansion rather than fundamental growth, and such valuation changes are finite, warranting caution.
  • Importance of Transaction Costs: Emphasised that a low turnover rate (0.19%) is key to cost control, and introduced the concept of "Total Cost of Investment (TCI)" to reveal transaction costs not captured by the OCF.
  • Reasons for Liquidations: Exited Schindler (overvalued), Serco (acquisition of an Indian BPO business led to cash flow deterioration), and Sigma-Aldrich (attempted acquisition of Life Technologies, detrimental to capital allocation discipline).